NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 45 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $9,000 | -70.0% | 22,799 | +41.6% | 0.00% | – |
Q1 2022 | $30,000 | -63.9% | 16,100 | -45.5% | 0.00% | – |
Q4 2021 | $83,000 | +27.7% | 29,528 | +64.0% | 0.00% | – |
Q3 2021 | $65,000 | -80.4% | 18,000 | -73.9% | 0.00% | – |
Q2 2021 | $332,000 | +88.6% | 69,077 | +190.0% | 0.00% | – |
Q1 2021 | $176,000 | -39.9% | 23,818 | -43.1% | 0.00% | – |
Q4 2020 | $293,000 | +44.3% | 41,849 | +56.6% | 0.00% | – |
Q3 2020 | $203,000 | -21.9% | 26,730 | -9.8% | 0.00% | – |
Q2 2020 | $260,000 | +205.9% | 29,618 | +150.6% | 0.00% | – |
Q4 2019 | $85,000 | – | 11,821 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CARNEGIE MELLON UNIVERSITY | 46,970 | $40,855 | 0.05% |